___

• Kaynaklar 1. Vas PRJ, Edmonds ME. Early recognition of diabeticperipheral neuropathy and the need for one-stop mic-rovascular assessment.Lancet Diabetes Endocrinol. 2016Sep;4(9):723-725. 2. Dimova R, Tankova T, Guergueltcheva V, Tournev I,Chakarova N, Grozeva G, et al. Risk factors for auto-nomic and somatic nerve dysfunction in different sta-ges of glucose tolerance. J Diabetes Complications. 2017Mar;31(3):537-543. 3. Ziegler D, Papanas N, Vinik AI, Shaw JE. Epidemiologyof polyneuropathy in diabetes and prediabetes. Handb ClinNeurol. 2014;126:3-22. 4. Papanas N, Ziegler D. Risk Factors and Comorbiditi-es in Diabetic Neuropathy: An Update 2015. Rev Dia-bet Stud. 2015 Spring-Summer;12(1-2):48-62. 5. Shaw JE, Hodge AM, de Courten M, Dowse GK, Ga-reeboo H, Tuomilehto J, et al. Diabetic neuropathy inMauritius: prevalence and risk factors. Diabetes Res ClinPract. 1998 Nov;42(2):131-9. 6. Morrison S, Colberg SR, Parson HK, Vinik AI. Relati-on between risk of falling and postural sway complexityin diabetes. Gait Posture. 2012 Apr;35(4):662-8. 7. Boulton AJ. The pathway to foot ulceration in diabetes.Med Clin North Am. 2013 Sep;97(5):775-90. 8. Perkins BA, Olaleye D, Zinman B, Bril V. Simple scree-ning tests for peripheral neuropathy in the diabetes cli-nic. Diabetes Care. 2001 Feb;24(2):250-6. 9. Callaghan BC, Kerber KA, Lisabeth LL, MorgensternLB, Longoria R, Rodgers A, et al. Role of neurologistsand diagnostic tests on the management of distalsymmetric polyneuropathy. JAMA Neurol. 2014 Sep;71(9):1143- 10. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Ca-nal N, Greene DA. A practical two-step quantitative cli-nical and electrophysiological assessment for the diag-nosis and staging of diabetic neuropathy. Diabetes Care.1994 Nov;17(11):1281-9. 11. Diabetes Control and Complications Trial Research Gro-up, Nathan DM, Genuth S, Lachin J, Cleary P, CroffordO, Davis M, et al. The effect of intensive treatment ofdiabetes on the development and progression of long-term complications in insulin-dependent diabetes mel-litus. N Engl J Med. 1993 Sep 30;329(14):977-86. 12. UK Prospective Diabetes Study (UKPDS) Group. Inten-sive blood-glucose control with sulphonylureas or in-sulin compared with conventional treatment and risk ofcomplications in patients with type 2 diabetes (UKPDS33). Lancet. 1998 Sep 12;352(9131):837-53. 13. Diabetes Control and Complications Trial Research Gro-up. Effect of intensive diabetes treatment on nerve con-duction in the Diabetes Control and Complications Tri-al. Ann Neurol. 1995 Dec;38(6):869-80. 14. Callaghan BC, Little AA, Feldman EL, Hughes RA. En-hanced glucose control for preventing and treating dia-betic neuropathy. Cochrane Database Syst Rev. 2012Jun 13;(6):CD007543. doi: 10.1002/14651858. 15. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, FreemanR, Malik RA, et al. Diabetic Neuropathy: A Position Sta-tement by the American Diabetes Association.DiabetesCare. 2017 Jan;40(1):136-154. 16. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dub-ner R. Effects of desipramine, amitriptyline, and fluo-xetine on pain in diabetic neuropathy. N Engl J Med.1992 May 7;326(19):1250-6. 17. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for trea-ting painful neuropathy or chronic pain. Cochrane Da-tabase Syst Rev. 2009 Oct 7;(4):CD007115. 18. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxineextended release in the treatment of painful diabetic neu-ropathy: a double-blind, placebo-controlled study.Pain. 2004 Aug;110(3):697-706. 19. Backonja MM. Use of anticonvulsants for treatment ofneuropathic pain. Neurology. 2002 Sep 10;59(5 Suppl2):S14-7. 20. Ametov AS, Barinov A, Dyck PJ, Hermann R, KozlovaN, Litchy WJ, et al; SYDNEY Trial Study Group. Thesensory symptoms of diabetic polyneuropathy are im-proved with alpha-lipoic acid: the SYDNEY trial. Dia-betes Care. 2003 Mar;26(3):770-6. 21. Bril V, England JD, Franklin GM, Backonja M, CohenJ, Del Toro D, et al; American Academy of Neurology;American Association of Neuromuscular and Electrodi-agnostic Medicine; American Academy of Physical Me-dicine and Rehabilitation. Evidence-based guideline: Tre-atment of painful diabetic neuropathy: report of the Ame-rican Academy of Neurology, the American Associationof Neuromuscular and Electrodiagnostic Medicine, andthe American Academy of Physical Medicine and Reha-bilitation. Muscle Nerve. 2011 Jun;43(6):910-7.